Form 4 Filing for Autolus Therapeutics plc

This filing details transactions by Director Elisabeth Leiderman on June 29, 2026. Leiderman acquired 31,667 Restricted Share Units (RSUs) with a post-transaction share count of 31,667, and 47,500 Share Options (Right to Buy) with a post-transaction share count of 47,500. The RSUs vest on June 29, 2027, and the share options vest in monthly installments starting July 29, 2026. Each RSU represents a contingent right to one American Depositary Share, which is convertible into one Ordinary Share. The exercise price for the share options is $1.61.